SEMBL is a potent NF-kappaB inhibitor that suppresses NF-kappaB-DNA binding activity and effectively reduces NF-kappaB-dependent inflammatory cytokine secretion, while also inhibiting cancer cell migration and invasion through downregulation of matrix metalloproteinase (MMP) expression, positioning SEMBL as a valuable research compound for studying inflammation-associated tumor progression and anticancer therapeutic mechanisms.
Molecular Weight:
233.22
CAS Number:
[1443448-82-5]
Formula:
C12H11NO4
Target:
NF-kappaB
T28749
T28749
* VAT and and shipping costs not included. Errors and price changes excepted
